Forget the Russell 2000. This Small-Cap Value Fund Beat It by 36% Over 5 Years

AVUV delivered a 71.36% return over the five years through June 15, 2026, beating IWM by 36.43 percentage points, while year-to-date it led 20.78% to 19.15%. The article argues that AVUV’s value and profitability screens improve small-cap exposure versus IWM’s unfiltered Russell 2000 approach, though it comes with a 0.25% fee versus 0.19% and more factor concentration. The piece is a comparative ETF recommendation rather than a market-moving event.

Analysis

This is less a statement about small caps as an asset class and more a reminder that index construction is a return driver. The market is implicitly paying a premium for “own everything” convenience, but the long-run penalty is that unprofitable, dilutive, or chronically capital-raising names dilute the compounding of the economically viable cohort. That matters most when rates are not collapsing, because cheap capital no longer rescues weak balance sheets as reliably as it did in the post-2020 period.

The second-order winner is not just AVUV; it is the broader ecosystem of profitable small-cap operators that can self-fund growth and avoid repeated equity issuance. Regional banks, select industrials, and cyclical value names gain mechanically from a higher weight in any factor-aware small-cap allocation, but the real edge is survivorship: fewer cash-burning laggards means less portfolio drag and less forced rebalancing into losers. The loser set is the marginal small-cap issuer that depends on a persistent bid for low-quality beta, because that bid is being selectively withdrawn.

The main risk is factor regime reversal, and the timing mismatch is measured in months to years, not days. If growth leadership broadens again or the Fed cuts aggressively enough to reflate long-duration equities, AVUV can underperform meaningfully even while its holdings do fine fundamentally. There is also embedded recession convexity in the portfolio tilt: if credit stress rises, the very sectors that screen well on profitability can still get hit harder than the benchmark because their balance sheets and earnings are more economically sensitive.

Consensus is treating this as a simple fee-versus-performance comparison, but the deeper question is whether investors want index purity or factor discipline. The overdone view is that one can just rotate to the best historical performer; the underdone view is that the opportunity here is persistent structural sorting inside small caps, especially if capital markets stay selective and profitability remains scarce. In that regime, AVUV is not merely an alternative ETF — it is a filter that converts a broad beta sleeve into a more deliberate exposure to the part of small caps that can actually compound.

Key Decisions for Investors

• Rotate new small-cap allocations from IWM into AVUV over the next 1-2 months; the cleaner way to harvest the factor edge is by avoiding fresh capital in the lower-quality tail rather than forcing a taxable switch.
• In taxable accounts, keep IWM and add AVUV only on dips or via ongoing contributions; the expected alpha is positive over a 3-5 year horizon, but the tax drag on realizing embedded gains can wipe out much of the near-term benefit.
• Pair trade: long AVUV / short IWM as a medium-horizon relative-value expression if the market enters a range-bound, non-momentum regime; this works best when rates are stable and equity breadth narrows away from mega-cap growth.
• Use AVUV as the core small-cap sleeve, but cap position size versus broad beta given recession sensitivity; a 5-10% allocation tilt is a more balanced way to express the view than an all-in replacement.
• If you expect a sharp growth-led rally or aggressive Fed easing, fade the rotation by trimming AVUV back toward IWM for 3-6 months; the risk/reward flips when low-quality duration becomes bid again.